Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Suzanne Arnold , Colin Barker, Start date: Aug 07, 2025
Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday… View more
Author(s): Santiago Garcia Added: 10 months ago
New York Valves 2025 - Early outcomes from an observational study with the PASCAL System show a 97% device success rate.Dr Santiago Garcia (The Christ Hospital, Cincinnati, OH, US) joins us to discuss a novel TEER device system. This observational study investigated the use of the PASCAL Prescision system in over 2000 patients from the STS/ACC/TVT registry over a period of two years.Findings… View more
Author(s): Sahil Parikh Added: 6 months ago
TCT 2025 - Three-year findings from LIFE-BTK show the Esprit™ BTK scaffold is a durable and effective treatment option for patients with CLTI.Dr Sahil Parikh (Columbia University Vagelos College of Physicians & Surgeons, New York, US) joins us to share the three-year findings from LIFE-BTK (NCT04227899). The randomized controlled trial aimed to evaluate the safety and efficacy of the Esprit™ BTK… View more
Research Area(s) / Expertise:
Author(s): Sarosh Khan , John Davies Added: 1 month ago
American College of Cardiology Congress 2026 - Dr Sarosh Khan and Dr John Davies (Essex Cardiothoracic Centre, Basildon, UK) join us to discuss results from the ORBITA-CTO trial (NCT05142215; Mid and South Essex NHS Foundation Trust), a randomised, placebo-controlled study evaluating CTO PCI versus placebo for the relief of stable angina.This double-blind, randomised, placebo-controlled pilot… View more
Author(s): Marten Falkenberg , Joakim Nordanstig Added: 8 months ago
ESC Congress 2025 - Paclitaxel-coated devices in critical limb threatening ischemia were not effective in preventing amputation, nor improving quality-of-life in intermittent claudication.Dr Mårten Falkenberg (Sahlgrenska University Hospital, Gothenburg, SE) and Prof Joakim Nordanstig (Sahlgrenska University Hospital, Gothenburg, SE) join us to discuss findings from the SWEDEPAD 1 and 2 parallel… View more
Author(s): Philipp Lurz Added: 8 months ago
ESC Congress 2025 - New findings from a post-hoc analysis of TRISCEND II show that TTVR can reduce the rate of heart failure hospitalisations, particularly in the case of patients who present with massive or torrential TR - irrespective of baseline TR severity.Prof Philipp Lurz (University Mainz, DE) discusses new findings from the TRISCEND II trial, examining how baseline tricuspid regurgitation… View more
Job title: Consultant Cardiologist & Electrophysiologist
Mauro Lencioni is a cardiologist at the Queen Elizabeth Hospital, Birmingham. His interests are the treatment of cardiac arrhythmias and the effects of arrhythmia symptoms on quality of life. View more
Improving Cardiovascular Health through Innovation The Cardiovascular Research Foundation (CRF) strives to improve the quality of life for patients with cardiovascular disease. Investigate CRF investigates early-stage technologies. We consult for new device and drug therapies, develop unique experimental models, and offer a full range of histopathology services and advanced cardiac imaging. … View more
Job title: Consultant Diabetologist
Dr Marc Evans is a Consultant Diabetologist based in Cardiff, Wales. He has been serving at the University Hospital Llandough since 2003, where he combines clinical practice with impactful research and education in diabetes care and chronic disease management. Prior to his current role, Dr Evans worked as a lecturer in diabetes and endocrinology at the University of Wales College of Medicine,… View more